Reversal of multi-drug resistance in K562/A02 cells by two short hairpin RNAs(shRNA) of mdr1 and mcll genes
Haiqing Yu
Abstract
Haiqing Yu
Abstract
Objective To construct two recombinant plasmids of mdrl and mell shRNA,and to in- vestigate their reversal effect on drug resistance in K562 adriamycin resistant cell lines(K562/A02).Meth- ods Two oligonucleotides of mdrl and mell gene were designed referring to that of GenBank,double-stran- ded DNA was derived through annealing,and cloned into pRNAT vector digested by two restricted endoen- zymes.K562/A02 cells were transfected with the recombinant plasmids.The mdrl mRNA expression and its protein product P-glycoprotein(P-gp)were detected by RT-PCR and flow cytometry.The expression of mell gene was detected by RT-PCR.50% inhibition concentration(IC_(50))of adriamycin(ADM)on K562/A02 cells was determined by MTT method.Cells apoptosis was analyzed by flow cytometry.Results Comparing with K562/A02 cells,the shRNA of mdrl or mell gene in vitro can remarkably increase the sensitivity of K562/A02 to adriamycin,down-regulate mdrl or mell gene expression,increase the K562/A02 cells apopto- sis rates induced by adriamycin.Cotransfection of mdrl and mell genes shRNA can also down-regulate the expression of their gene,more remarkably increase the sensitivity and apoptosis of K562/A02 to adriamycin. Conclusion Transfection of mdrl or mell gene shRNA can promote the sensitivity of K562/A02 to adriamy- cin and cotransfection of the two shRNA can more remarkably do so.The mell gene might be involved in adri- amycin resistant in K562/A02 cells.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To construct two recombinant plasmids of mdrl and mell shRNA,and to in- vestigate their reversal effect on drug resistance in K562 adriamycin resistant cell lines(K562/A02).Meth- ods Two oligonucleotides of mdrl and mell gene were designed referring to that of GenBank,double-stran- ded DNA was derived through annealing,and cloned into pRNAT vector digested by two restricted endoen- zymes.K562/A02 cells were transfected with the recombinant plasmids.The mdrl mRNA expression and its protein product P-glycoprotein(P-gp)were detected by RT-PCR and flow cytometry.The expression of mell gene was detected by RT-PCR.50% inhibition concentration(IC_(50))of adriamycin(ADM)on K562/A02 cells was determined by MTT method.Cells apoptosis was analyzed by flow cytometry.Results Comparing with K562/A02 cells,the shRNA of mdrl or mell gene in vitro can remarkably increase the sensitivity of K562/A02 to adriamycin,down-regulate mdrl or mell gene expression,increase the K562/A02 cells apopto- sis rates induced by adriamycin.Cotransfection of mdrl and mell genes shRNA can also down-regulate the expression of their gene,more remarkably increase the sensitivity and apoptosis of K562/A02 to adriamycin. Conclusion Transfection of mdrl or mell gene shRNA can promote the sensitivity of K562/A02 to adriamy- cin and cotransfection of the two shRNA can more remarkably do so.The mell gene might be involved in adri- amycin resistant in K562/A02 cells.
Key concepts: Transfection, Small hairpin RNA, Molecular biology, K562 cells, Flow cytometry, Recombinant DNA, Gene, Biology